The Global European: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Global European.

Press releases published on November 9, 2026

Nov. 9, 2026

큐리아 (Curia), 스페인 레온 사업장 발효 생산능력 확대

Indeterminate GlobeNewswire

Nov. 9, 2026

Curia Memperluas Kapasiti Penapaian di León, Sepanyol

Indeterminate GlobeNewswire

Nov. 9, 2026

Curia Expande Capacidade de Fermentação em León, Espanha

Indeterminate GlobeNewswire

Nov. 9, 2026

Curia ขยายกำลังการผลิตด้วยการหมักที่เมืองเลออน ประเทศสเปน

Indeterminate GlobeNewswire

Nov. 9, 2026

Curia 于西班牙莱昂扩大发酵产能

Indeterminate GlobeNewswire

Nov. 9, 2026

Curia 擴展在西班牙萊昂的發酵產能

Indeterminate GlobeNewswire

Nov. 9, 2026

Marea Therapeutics, a Subsidiary of Lisata Therapeutics, Announces MAR001 Reduces Triglycerides Without Worsening Glycemic Control in Phase 2b TYDAL-TIMI 78 Trial; Results Presented as AHA 2026 Late-Breaker and Published in The New England Journal of…

Indeterminate GlobeNewswire

Nov. 9, 2026

AnorTech Closes Final C$7.55 Million Share Exchange; Nasdaq-Listed Greenland Mines Now Holds 19.9%

Indeterminate GlobeNewswire

Nov. 9, 2026

NewcelX Announces Pricing of $1.55 Million Equity Financing at 20% Premium Pricing to Market

Indeterminate GlobeNewswire

Nov. 9, 2026

EuroHoldings Ltd. Sets Date for the Release of Third Quarter 2026 Results, Conference Call and Webcast

Indeterminate GlobeNewswire

Nov. 9, 2026

Nordic American Tankers Ltd (NYSE: NAT) - The Tanker Bonanza continues

Indeterminate GlobeNewswire

Nov. 9, 2026

NeOnc CEO Adds Another 70,000 Shares as Insider Buying Continues

Indeterminate GlobeNewswire

Nov. 9, 2026

Biodexa provides R&D Update

Indeterminate GlobeNewswire

Nov. 9, 2026

Veru to Present New Results on Effects of Enobosarm on Physical Function in Older Patients Receiving GLP-1 RA from the Phase 2b QUALITY clinical study at ObesityWeek 2026

Indeterminate GlobeNewswire

Nov. 9, 2026

Polaryx Therapeutics Activates First Clinical Trial Site for SOTERIA Phase 2 Basket Trial of PLX-200

Indeterminate GlobeNewswire

Nov. 9, 2026

Vistagen Provides Regulatory Update Following Productive Type C Meeting with U.S. FDA on Phase 3 Development of Fasedienol for Social Anxiety Disorder

Indeterminate GlobeNewswire

Nov. 9, 2026

ALPHAMIN TO SUPPLY BISIE TIN CONCENTRATE TO NEW US SMELTER

Indeterminate GlobeNewswire

Nov. 9, 2026

SCHMID Group Secures Key Wet-Process Equipment Order for South Asia’s First Glass Core Substrate Manufacturing Facility

Indeterminate GlobeNewswire

Nov. 9, 2026

STMicroelectronics announces status of common share repurchase program

Indeterminate GlobeNewswire

Nov. 9, 2026

Evaxion files amendment to registration statement related to 2025 EIB debt settlement agreement

Indeterminate GlobeNewswire